Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 224,704 shares at $91.79 ($20.6M) on 2024-11-27, disclosed to the SEC on 2024-11-29.
Scheduled sale ($20.6M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.79 | 57,294 | $5.3M | 25.5% |
| 2 | $91.79 | 57,294 | $5.3M | 25.5% |
| 3 | $91.80 | 3,199 | $294K | 1.4% |
| 4 | $91.80 | 5,200 | $477K | 2.3% |
| 5 | $91.80 | 3,199 | $294K | 1.4% |
| 6 | $92.00 | 10,399 |
| $957K |
| 4.6% |
| 7 | $92.00 | 88,119 | $8.1M | 39.3% |
| Total | $91.88 avg | 224,704 | $20.6M | 100% |
| Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |
| GILD | SELL | 2024-04-02 | $146K | — | Filing → |